Effective Friday, September 4, 2015, a new functionality for Sunshine Act reporting is being implemented by Bristol-Myers Squibb within our Grant Management System (CyberGrants). This new functionality will replace the Excel template that was required to be completed and submitted to the Grant Analysts at BMS. Now, the sunshine reporting for a grant can be completed from within the applicant portal. This new feature will enable you to enter and submit the indirect Payments or Transfer of Value more easily and communicate with BMS through a secure portal. What you should do to make the transition smooth:
1. Click here to access the training materials that provide information on how this new functionality works.
2. Click here to read FAQs regarding the new Sunshine Act reporting feature.
BMS is upgrading its Corporate Giving system on Friday, May 16th. The new system will enable you to more easily track the status of your requests and communicate with BMS through a secure portal for requests for additional information about your applications, contracting, outcomes and eventually, Sunshine Act reporting.
What you can do to make the transition smooth:
- Review the training materials that provide information on how the new system works. New BMS Corporate Giving System Instructions
- After Friday, create an applicant account and password for the new system. (You don’t need to do this until you are ready to submit a new request, but the system will be open for you to familiarize yourself with our new applications.)
Any existing requests that you have submitted through our old request system will be migrated to our new system in late June, so no further action is necessary on any existing application with regard to this transition.
Recently, Bristol-Myers Squibb divested ownership of its Metabolic interests, and those interests were acquired by AstraZeneca. As a result, Bristol-Myers Squibb will no longer be accepting new Metabolic-related grant applications. To request a contribution from AstraZeneca, nonprofit organizations may access the AstraZeneca corporate giving application at:
Bristol-Myers Squibb considers requests for charitable donations from a broad range of health care-related charitable organizations.
Requests must be made in connection with a general fundraising effort by the charitable entity, rather than a request directed only to Bristol-Myers Squibb. In addition, the request must come from an organization employee and not from an individual physician, pharmacist, or health care professional who is not an employee of the charity.
How to apply for a Corporate Charitable Donation, including fundraising events such as walks.
In addition to supporting an organization’s mission or general activities with a charitable donation, Bristol-Myers Squibb may also supports the following:
Sponsorships and Support for Specific Activities
Fellowships, Scholarships and Awards
FAQs, Forms, Guidelines & Reporting Resources for the Physician Payment Sunshine Act